Suppr超能文献

导管原位癌背景下乳腺磁共振成像的进展

Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

作者信息

Amornsiripanitch Nita, Lam Diana L, Rahbar Habib

机构信息

University of Massachusetts Memorial Medical Center, Worcester, MA.

University of Washington, Seattle Cancer Care Alliance, Seattle, WA.

出版信息

Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.

Abstract

Ductal carcinoma in situ (DCIS) of the breast is a pre-invasive breast malignancy with controversial clinical relevance and management. These lesions have increased in incidence with breast cancer screening programs and are associated with increasingly recognized clinical issues of overdiagnosis and overtreatment. This article discusses the imaging presentation of these lesions with emphasis on advances in breast MRI and its role in the management of DCIS.

摘要

乳腺导管原位癌(DCIS)是一种乳腺浸润前恶性肿瘤,其临床相关性和管理存在争议。随着乳腺癌筛查项目的开展,这些病变的发病率有所上升,并与越来越多被认识到的过度诊断和过度治疗等临床问题相关。本文讨论这些病变的影像学表现,重点是乳腺磁共振成像(MRI)的进展及其在DCIS管理中的作用。

相似文献

1
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.导管原位癌背景下乳腺磁共振成像的进展
Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.
2
Ductal carcinoma in situ and breast MRI.导管原位癌与乳腺磁共振成像
Lancet. 2007 Aug 11;370(9586):459-60. doi: 10.1016/S0140-6736(07)61207-0.

本文引用的文献

5
Cancer statistics: Breast cancer in situ.癌症统计数据:原位乳腺癌。
CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95. doi: 10.3322/caac.21321. Epub 2015 Oct 2.
6
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?3T磁共振成像生物标志物能否识别低风险导管原位癌?
Clin Imaging. 2016 Jan-Feb;40(1):125-9. doi: 10.1016/j.clinimag.2015.07.026. Epub 2015 Jul 26.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验